Hormone replacement therapy [topp]
Reactive [qlco]
Monocytes [cell]
Platelets [cell]
whole blood [bdsu]
Effect [qlco]
Atherogenesis [patf]
Thrombus [patf]
formation [biof]
Objective [inpr]
Purpose [ftcn]
To [qlco]
investigate [ftcn]
effects [qlco]
Hormone replacement therapy [topp]
Reactive [qlco]
Monocytes [cell]
Platelets [cell]
whole blood [bdsu]
Measured [qlco]
Tissue Factor [aapp, imft]
activity [dora]
tumor necrosis factor-alpha [aapp, imft]
Study Design [resa]
Two [qnco]
Women [popg]
randomized [resa]
Transdermal [ftcn]
Oral [spco]
Combined [qlco]
Hormone replacement therapy [topp]
Blood sampling [diap]
months [tmco]
treatment [ftcn]
Tissue Factor [aapp, imft]
activity [dora]
Monocytes [cell]
Measured [qlco]
Unstimulated [qlco]
whole blood [bdsu]
Weak [sosy]
Lipopolysaccharide [lipd]
Stimulation [topp]
tumor necrosis factor-alpha [aapp, imft]
formation [biof]
Plasma [bdsu]
Measured [qlco]
Weak [sosy]
Lipopolysaccharide [lipd]
Stimulation [topp]
whole blood [bdsu]
Result [ftcn]
months [tmco]
Hormone replacement therapy [topp]
reductions [npop]
Tissue Factor [aapp, imft]
activity [dora]
Unstimulated [qlco]
Lipopolysaccharide [lipd]
Stimulated [npop]
Monocytes [cell]
P NOS [aapp, imft]
reductions [npop]
formation [biof]
tumor necrosis factor-alpha [aapp, imft]
P NOS [aapp, imft]
P NOS [aapp, imft]
Parameters [fndg]
Transdermal [ftcn]
Oral [spco]
Group [idcn]
Observed [ftcn]
therapy [ftcn]
Conclusion [idcn]
Twelve [qnco]
months [tmco]
Hormone replacement therapy [topp]
Cellular [cell]
Activation [acty]
blood monocytes [cell]
Platelets [cell]
account [idcn]
effects [qlco]
Reducing [qlco]
Risk [qlco]
Cardiovascular disease [dsyn]
